{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:26:13Z","timestamp":1787073973689,"version":"build-2736575974"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154311","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:24:49Z","timestamp":1784355889000},"page":"154311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Precision prime editing of TP53 mutations for functional tumor suppression in colorectal cancer"],"prefix":"10.1016","volume":"831","author":[{"given":"Md","family":"Azhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-6149","authenticated-orcid":false,"given":"Rishabha","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phool","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Belagodu","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javedh","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154311_bib1","unstructured":"Colorectal cancer.\u201d Accessed: April. 9, 2026. [Online]. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1186\/s12885-025-15138-0","article-title":"Global burden of colorectal cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/jgh.16910","article-title":"Incidence and mortality of colorectal cancer in Asia in 2022 and projections for 2050","volume":"40","author":"Fu","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00428-024-03746-3","article-title":"Molecular pathological classification of colorectal cancer\u2014an update","volume":"484","author":"Dunne","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbrc.2026.154311_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102374","article-title":"Understanding the cellular and molecular heterogeneity in colorectal cancer through the use of single-cell RNA sequencing","volume":"55","author":"Chen","year":"2025","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00428-016-1956-3","article-title":"Molecular pathological classification of colorectal cancer","volume":"469","author":"M\u00fcller","year":"2016","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41434-024-00499-1","article-title":"Prime editing: therapeutic advances and mechanistic insights","volume":"32","author":"Murray","year":"2024","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumor suppression?","volume":"25","author":"Aubrey","year":"2017","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.20106","article-title":"The TP53 tumor suppressor gene: from molecular biology to clinical investigations","volume":"298","author":"Baliakas","year":"2025","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tig.2022.02.010","article-title":"The p53 network: cellular and systemic DNA damage responses in cancer and aging","volume":"38","author":"Vaddavalli","year":"2022","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/s12967-025-06566-4","article-title":"p53 in colorectal cancer: from a master player to a privileged therapy target","volume":"23","author":"Yan","year":"2025","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154311_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jmcb\/mjy075","article-title":"Mutant p53 in colon cancer","volume":"11","author":"Nakayama","year":"2019","journal-title":"J. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154311_bib17","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.celrep.2019.08.061","article-title":"Erratum: integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why are there hotspot mutations in the TP53 gene in human cancers?","volume":"25","author":"Baugh","year":"2017","journal-title":"Cell Death Differ."},{"issue":"6453","key":"10.1016\/j.bbrc.2026.154311_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aax3649","article-title":"A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies","volume":"365","author":"Boettcher","year":"1979","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.bbrc.2026.154311_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312928","article-title":"Unraveling the guardian: p53's multifaceted role in the DNA damage response and tumor treatment strategies","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154311_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154311_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092125","article-title":"The role of p53 signaling in colorectal cancer","volume":"13","author":"Liebl","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib24","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-022-30481-7","article-title":"Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients","volume":"13","author":"Hassin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154311_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17929","article-title":"TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions","volume":"5","author":"Shirole","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.bbrc.2026.154311_bib26","doi-asserted-by":"crossref","DOI":"10.48101\/ujms.v129.10719","article-title":"Therapeutic targeting of TP53 nonsense mutations in cancer","volume":"129","author":"Strandgren","year":"2024","journal-title":"Upsala J. Med. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib27","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/cas.16162","article-title":"Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line","volume":"115","author":"Nguyen","year":"2024","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/cdd.2013.53","article-title":"Not all p53 gain-of-function mutants are created equal","volume":"20","author":"Mello","year":"2013","journal-title":"Cell Death Differ."},{"issue":"36","key":"10.1016\/j.bbrc.2026.154311_bib29","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1021\/acs.jpcb.3c04700","article-title":"Elucidating the mechanisms of R248Q mutation-enhanced p53 aggregation and its inhibition by resveratrol","volume":"127","author":"Liu","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154311_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/curroncol32090488","article-title":"Correlation of TP53 genetic alterations with p53 immunohistochemical expression and their prognostic significance in DLBCL","volume":"32","author":"Chen","year":"2025","journal-title":"Curr. Oncol."},{"issue":"24","key":"10.1016\/j.bbrc.2026.154311_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412080","article-title":"TP53 splice mutations have tumour-independent effects on genomic stability and prognosis: an In silico study","volume":"26","author":"Bhandarkar","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib32","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.62347\/KTYO7957","article-title":"Relationship between Ki-67 and P53 immunohistochemical expression and osteosarcoma chemotherapy sensitivity and long-term prognosis","volume":"17","author":"Z","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"7785","key":"10.1016\/j.bbrc.2026.154311_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/cells14040277","article-title":"Prime editing: mechanistic insights and DNA repair modulation","volume":"14","author":"Mentani","year":"2025","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s12276-025-01463-8","article-title":"Emerging trends in prime editing for precision genome editing","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154311_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179862","article-title":"Prime editing: an all-rounder for genome editing","volume":"23","author":"Lu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bbrc.2026.154311_bib37","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154311_bib38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41467-022-28442-1","article-title":"Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair","volume":"13","author":"Ferreira da Silva","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154311_bib40","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2026.154311_bib41","unstructured":"Comparison between prime editing and CRISPR-Cas9 - CD genomics.\u201d Accessed: April. 11, 2026. [Online]. Available: https:\/\/bioinfo.cd-genomics.com\/resource-comparison-between-prime-editing-and-crispr-cas9.html."},{"issue":"7681","key":"10.1016\/j.bbrc.2026.154311_bib42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of T to G C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12915-020-00866-5","article-title":"ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems","volume":"18","author":"Xie","year":"2020","journal-title":"BMC Biol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102344","article-title":"CRISPR-Cas9-mediated homology-directed repair for precise gene editing","volume":"35","author":"Liao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"17","key":"10.1016\/j.bbrc.2026.154311_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172665","article-title":"Applications of CRISPR\/Cas13-Based RNA editing in plants","volume":"11","author":"Kavuri","year":"2022","journal-title":"Cells"},{"issue":"6366","key":"10.1016\/j.bbrc.2026.154311_bib46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"issue":"7785","key":"10.1016\/j.bbrc.2026.154311_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154311_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1039315","article-title":"Current advancement in the application of prime editing","volume":"11","author":"Huang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41587-021-01133-w","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","volume":"40","author":"Anzalone","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib51","article-title":"CRISPR\/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"issue":"7603","key":"10.1016\/j.bbrc.2026.154311_bib52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/srep23549","article-title":"Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing","volume":"6","author":"Miyaoka","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154311_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nbt.4194","article-title":"Optimized base editors enable efficient editing in cells, organoids and mice","volume":"36","author":"Zafra","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41587-021-01025-z","article-title":"Precise genomic deletions using paired prime editing","volume":"40","author":"Choi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.154311_bib56","first-page":"1","article-title":"Directed evolution of small RNA-stabilizing motifs that improve prime-editing efficiency","author":"Sakai","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib58","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.tibtech.2026.02.002","article-title":"Omega-based mini prime- and base-editing systems in Escherichia coli","volume":"44","author":"Liu","year":"2026","journal-title":"Trends Biotechnol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib59","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000940","article-title":"Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids","volume":"4","author":"Geurts","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib60","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41587-024-02172-9","article-title":"High-throughput evaluation of genetic variants with prime editing sensor libraries","volume":"43","author":"Gould","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154311_bib61","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3390\/cancers13164088","article-title":"The function of the mutant p53-R175H in cancer","volume":"13","author":"Chiang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bpj.2019.12.015","article-title":"Variable mutations at the p53-R273 oncogenic hotspot position leads to altered properties","volume":"118","author":"Garg","year":"2019","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.8","article-title":"Gain of function of mutant p53: R282W on the peak?","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41592-024-02502-4","article-title":"A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening","volume":"22","author":"Cirincione","year":"2024","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib66","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"Van De Wetering","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib67","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nm.4355","article-title":"Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing","volume":"23","author":"Crespo","year":"2017","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14262","article-title":"Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors","volume":"8","author":"Sch\u00fctte","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/ijc.34297","article-title":"From organoids to bedside: advances in modeling, decoding and targeting of colorectal cancer","volume":"152","author":"Betge","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt.3837","article-title":"Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer","volume":"35","author":"O'Rourke","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae277","article-title":"Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy","volume":"30","author":"Ruzzo","year":"2025","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.3836","article-title":"In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis","volume":"35","author":"Roper","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13046-017-0647-5","article-title":"Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53","volume":"36","author":"Terranova-Barberio","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib75","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s42003-022-04055-8","article-title":"Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient\/KRASG12D glycolytic colorectal tumors","volume":"5","author":"Ludikhuize","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41419-025-07902-8","article-title":"Valproic acid improves the efficacy of oxaliplatin\/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via \u03b2-Catenin modulation in colorectal cancer","volume":"16","author":"Roca","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.66068\/mjaabu.v3i1.49","article-title":"Evaluation of the effect of valproic acid on 5-fluorouracil cytotoxicity on colon cancer cells. An in vitro study","volume":"3","author":"Mahdi","year":"2024","journal-title":"Medical Journal of Ahl al-Bayt University"},{"key":"10.1016\/j.bbrc.2026.154311_bib78","article-title":"Delivery of gene editing therapeutics","volume":"54","author":"Kevadiya","year":"2023","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060763","article-title":"Emerging perspectives on prime editor delivery to the brain","volume":"17","author":"BenDavid","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102457","article-title":"Advanced delivery systems for gene editing: a comprehensive review from the GenE-HumDi COST action working group","volume":"36","author":"Cavazza","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.154311_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103071","article-title":"Recent advances in prime editing technologies and their promises for therapeutic applications","volume":"86","author":"Zeng","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41587-023-01758-z","article-title":"Efficient prime editing in mouse brain, liver and heart with dual AAVs","volume":"42","author":"Davis","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib83","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"18","key":"10.1016\/j.bbrc.2026.154311_bib84","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1093\/nar\/gkad676","article-title":"Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR\/cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification","volume":"51","author":"Haldrup","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib86","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1089\/genbio.2023.0045","article-title":"In vivo prime editing by lipid nanoparticle Co-Delivery of chemically modified pegRNA and prime editor mRNA","volume":"2","author":"Chen","year":"2023","journal-title":"GEN Biotechnology"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib87","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41467-024-55604-0","article-title":"Delivery of prime editing in human stem cells using pseudoviral NanoScribes particles","volume":"16","author":"Halegua","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2020.10.014","article-title":"CRISPR-cas tools and their application in genetic engineering of human stem cells and organoids","volume":"27","author":"Hendriks","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13808","article-title":"Prime editing: a revolutionary technology for precise treatment of genetic disorders","volume":"58","author":"Li","year":"2025","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154311_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658399","article-title":"Anti-AAV antibodies in AAV gene therapy: current challenges and possible solutions","volume":"12","author":"Weber","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib92","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bbrc.2026.154311_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.670124","article-title":"Orally administrable therapeutic nanoparticles for the treatment of colorectal cancer","volume":"9","author":"Ying","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10616-020-00442-3","article-title":"Encorafenib enhances TRAIL-induced apoptosis of colorectal cancer cells dependent on p53\/PUMA signaling","volume":"73","author":"Sun","year":"2020","journal-title":"Cytotechnology"},{"issue":"24","key":"10.1016\/j.bbrc.2026.154311_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417488","article-title":"CDKN1A\/p21 in breast cancer: part of the problem, or part of the solution?","volume":"24","author":"Manousakis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10010098","article-title":"Antitumor effects of PRIMA-1 and PRIMA-1Met (APR246) in hematological malignancies: still a mutant P53-Dependent affair?","volume":"10","author":"Menichini","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib98","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2907272","article-title":"Unraveling the role of TP53 in colorectal cancer therapy: from wild-type regulation to mutant","volume":"29","author":"Li","year":"2024","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib99","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/biom10030420","article-title":"Role of p53 in the regulation of cellular senescence","volume":"10","author":"Mijit","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib101","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/radiation4040023","article-title":"Exploring the role of p53 in radiosensitivity: a key player in cancer therapy","volume":"4","author":"Al-Arafat","year":"2024","journal-title":"Radiation"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib102","doi-asserted-by":"crossref","DOI":"10.31083\/FBL44663","article-title":"Deciphering the role of KIF18A in Osteosarcoma progression: an integrative analysis and experimental validation","volume":"30","author":"Gu","year":"2025","journal-title":"Front. Biosci. (Landmark Ed)."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154311_bib103","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","article-title":"The role of p53 in cancer drug resistance and targeted chemotherapy","volume":"8","author":"Hientz","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12033-022-00580-3","article-title":"Prime editing: an emerging tool in cancer treatment","volume":"65","author":"Sen","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.23922\/jarc.2020-064","article-title":"Immunotherapy in colorectal cancer: current and future strategies","volume":"5","author":"Ooki","year":"2021","journal-title":"J. Anus Rectum Colon"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib106","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41392-020-00358-6","article-title":"Development of synthetic lethality in cancer: molecular and cellular classification","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154311_bib107","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2217\/fon.10.132","article-title":"Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy","volume":"6","author":"Martinez","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrc.2026.154311_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.014","article-title":"The role of phenotypic plasticity in the escape of cancer cells from targeted therapy","volume":"122","author":"Emmons","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"8087","key":"10.1016\/j.bbrc.2026.154311_bib109","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41586-025-09537-3","article-title":"Engineered prime editors with minimal genomic errors","volume":"646","author":"Chauhan","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41551-024-01233-3","article-title":"Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells","volume":"9","author":"Sousa","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41467-024-55578-z","article-title":"Mismatch prime editing gRNA increased efficiency and reduced indels","volume":"16","author":"Fei","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41467-023-35919-0","article-title":"Enhancement of a prime editing system via optimal recruitment of the pioneer transcription factor P65","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"issue":"8008","key":"10.1016\/j.bbrc.2026.154311_bib113","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-024-07259-6","article-title":"Improving prime editing with an endogenous small RNA-binding protein","volume":"628","author":"Yan","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib114","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/cells13100858","article-title":"Prime editing and DNA repair system: balancing efficiency with safety","volume":"13","author":"Daliri","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bsheal.2025.05.003","article-title":"Biosafety considerations triggered by genome-editing technologies","volume":"7","author":"Li","year":"2025","journal-title":"Biosaf. Health"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41389-021-00342-x","article-title":"Tumour heterogeneity and evolutionary dynamics in colorectal cancer","volume":"10","author":"Chan","year":"2021","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96204-2","article-title":"Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity","volume":"15","author":"Kratz","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154311_bib118","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41419-024-07266-5","article-title":"Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance","volume":"15","author":"Esposito","year":"2024","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib119","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.ymthe.2025.06.045","article-title":"Peeling back the layers of immunogenicity in Cas9-based genomic medicine","volume":"33","author":"Stigzelius","year":"2025","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib120","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/cancers13102296","article-title":"The role of p53 dysfunction in colorectal cancer and its implication for therapy","volume":"13","author":"Michel","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib121","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3892\/etm.2020.8818","article-title":"TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents","volume":"20","author":"Yang","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib122","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.stemcr.2021.06.004","article-title":"Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing","volume":"16","author":"Zeps","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154311_bib123","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3390\/ijms27031484","article-title":"From bench to bedside: ethical and clinical best practices for genome editing applications","volume":"27","author":"Ortiz-Bueno","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154311_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1589034","article-title":"Systematic optimization of prime editing for enhanced efficiency and versatility in genome engineering across diverse cell types","volume":"13","author":"Mu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"8028","key":"10.1016\/j.bbrc.2026.154311_bib125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","article-title":"The genomic landscape of 2,023 colorectal cancers","volume":"633","author":"Cornish","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154311_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70040","article-title":"Prime editing: the next frontier in precision gene therapy","volume":"27","author":"Aliciaslan","year":"2025","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bbrc.2026.154311_bib127","article-title":"Non-clinical safety considerations on genome editing using the CRISPR\/cas system","author":"Toofan","year":"2025","journal-title":"Genes Dis."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401632","article-title":"Lipid nanoparticles for delivery of CRISPR gene editing components","volume":"10","author":"Wu","year":"2025","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154311_bib129","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/s41467-025-58653-1","article-title":"Modified pegRNAs mitigate scaffold-derived prime editing by-products","volume":"16","author":"Antoniou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154311_bib130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90948.2","article-title":"Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions","volume":"12","author":"Zhang","year":"2024","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154311_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114511","article-title":"Advances in mitochondrial-targeted colorectal cancer therapy: mechanistic insights and clinical translation","volume":"29","author":"Che","year":"2026","journal-title":"iScience"},{"issue":"22","key":"10.1016\/j.bbrc.2026.154311_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223870","article-title":"Precision medicine for metastatic colorectal cancer: where do we stand?","volume":"16","author":"Underwood","year":"2024","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154311_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/life14111358","article-title":"Companion diagnostics (CDx) based on molecular biology techniques","volume":"14","author":"Kang","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bbrc.2026.154311_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114225","article-title":"Empowering effective biomarker-driven precision oncology: a call to action","volume":"209","author":"Lawler","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154311_bib135","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1158\/2159-8290.CD-24-1476","article-title":"Precision oncology: 2024 in review","volume":"14","author":"Repetto","year":"2024","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154311_bib136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14737159.2022.2100697","article-title":"The value of companion diagnostics in oncology drug development","volume":"22","author":"Conn","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154311_bib137","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2024.2317976","article-title":"The impact of companion diagnostic testing on medical decision making and IVD regulations","volume":"24","author":"J\u00f8rgensen","year":"2024","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.bbrc.2026.154311_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1506606","article-title":"Advances in the application of colorectal cancer organoids in precision medicine","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154311_bib139","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154311_bib140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:24Z","timestamp":1787070864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":139,"alternative-id":["S0006291X26010752"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154311","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision prime editing of TP53 mutations for functional tumor suppression in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154311"}}